Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: Fasting on Newly Diagnosed Breast Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating fasting in newly diagnosed HER2-positive breast cancer was terminated, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-11-07Clinical Trial Update: Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating temsirolimus combined with neratinib in metastatic HER2-amplified or triple-negative breast cancer; results poste…
-
CLINICAL_TRIALS trial_result · 2017-11-07Clinical Trial Update: Reusable Versus Disposable Draping System in Breast Reconstruction Surgery [NA]
A completed clinical trial comparing reusable versus disposable draping systems in breast reconstruction surgery after mastectomy.
-
CLINICAL_TRIALS trial_result · 2017-11-07Clinical Trial Update: A 5 Year Follow-up on Newly Diagnosed Breast Cancer Patients
A 5-year follow-up study in patients with newly diagnosed breast cancer has been terminated, according to the clinical trials registry entry…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Study of Neoadjuvant Myocet®, Paclitaxel, Pertuzumab, and Trastuzumab in HER2-positive Breast Cancer [Phase 2]
Phase 2 neoadjuvant trial evaluating a quad-therapy regimen (liposomal doxorubicin/Myocet, paclitaxel, pertuzumab, and trastuzumab) in HER2-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Pharmacogenomic Study of Neoadjuvant Eribulin for HER2 Non-overexpressing Breast Cancer [Phase 2]
This clinical trial update reports results from a Phase 2 pharmacogenomic study of neoadjuvant eribulin in HER2 non-overexpressing breast ca…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer [Phase 2]
Phase 2 trial evaluating prophylactic topical agents to lessen radiation-induced dermatitis in patients undergoing breast cancer radiotherap…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer [Phase 2]
Phase 2 trial comparing neratinib plus paclitaxel to trastuzumab plus paclitaxel in ErbB-2 positive advanced breast cancer has completed wit…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study) [Phase 2]
Phase 2 ABRAZO study of talazoparib in locally advanced/metastatic breast cancer with BRCA mutations terminated; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer. [Phase 1]
Phase I trial evaluating the combination of afatinib and trastuzumab in HER2-overexpressing cancers (breast and stomach), with the study com…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast Cancer [Phase 1]
A Phase 1 study assessing intrapleural bevacizumab after pleural drainage in patients with malignant pleural effusion due to breast cancer; …
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel [NA]
A clinical trial evaluating acupuncture to treat nerve pain in breast cancer patients receiving paclitaxel has been terminated. The study in…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Diindolylmethane in Treating Patients With Breast Cancer [NA]
A University of Arizona–sponsored clinical trial evaluating diindolylmethane in breast cancer patients has completed, enrolling patients acr…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: REaCT Integrated Consent Model to Compare Two Standard of Care Regimens [Phase 4]
This Phase 4 study evaluates an integrated consent model for comparing two standard-of-care regimens in breast cancer.
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Acupuncture for Aromatase Inhibitor Induced Joint Pain [NA]
Clinical trial update indicating a Columbia University study on acupuncture for aromatase inhibitor–induced joint pain in breast cancer pati…
-
FDA approval · 2017-11-03FDA Approved: DOXORUBICIN HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for doxorubicin hydrochloride from BluePoint Laboratories, adding a new approved generic version of …
-
CLINICAL_TRIALS other · 2017-10-31Clinical Trial Update: Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
Expanded access program for abemaciclib (Verzenio) for metastatic breast cancer has been approved for marketing. This enables broader patien…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer
This update reports the completion of a clinical trial evaluating early detection of taxane-induced peripheral neuropathy in women with brea…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Limonene Study in Women With Breast Cancer [Phase 1]
A Phase 1 clinical trial evaluating limonene in women with breast cancer has completed.
-
CLINICAL_TRIALS research · 2017-10-27Clinical Trial Update: Psychosocial Intervention Pilot for Partners in BRCA Testing [NA]
A completed pilot clinical trial evaluating a psychosocial intervention for partners of individuals undergoing BRCA genetic testing in the c…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Telehealth System to Improve Quality of Life in Breast Cancer Survivors [NA]
A completed clinical trial evaluating a telehealth system intended to improve quality of life for breast cancer survivors.
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: VEGF-targeted Fluorescent Tracer Imaging in Breast Cancer [Phase 1]
Phase 1 clinical trial investigating a VEGF-targeted fluorescent tracer for imaging breast cancer has completed. The sponsor is University M…
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Intraoperative Indocyanine Green Laser Angiography; Postoperative Outcomes for Autologous Tissue Flaps
Completed clinical trial evaluating intraoperative indocyanine green laser angiography to assess postoperative outcomes in autologous tissue…
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Study of Tumor RNA Disruption Assay™ (RDA) [NA]
A clinical trial evaluating the Tumor RNA Disruption Assay (RDA) for breast cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: Study of Neoadjuvant Treatment of Locally Advanced Breast Cancer With CAP Regimen [Phase 2]
A Phase 2 neoadjuvant trial evaluating the CAP regimen (cyclophosphamide, doxorubicin, paclitaxel) for locally advanced breast cancer, inclu…